CG Invites Co., Ltd.

Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.

083790 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
Website:: https://cginvites.com/en
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized precision medicine. Leveraging its core competency in developing novel chemical and biological drugs—such as Acelex (osteoarthritis), Ivaltinostat (pancreatic cancer), and Camrelizumab (immuno-oncology)—the company has expanded its focus to several key areas. These include whole genome sequencing, contributing to large-scale bio-data projects; the development of personalized, mRNA-based cancer vaccines targeting tumor-specific neoantigens; and digital therapeutics (DTx), exemplified by its HealthOnG platform for diabetes management. The company's strategy is to innovate within the digital genome market by integrating its drug development expertise with cutting-edge genomic and digital health technologies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CG Invites Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size
2025-08-14 00:00	Interim Report 반기보고서 (2025.06)	Korean	1.8 MB
2025-08-14 00:00	Major Shareholding Notification 임원ㆍ주요주주특정증권등소유상황보고서	Korean	34.7 KB
2025-08-08 00:00	Annual Report [기재정정]사업보고서 (2024.12)	Korean	2.7 MB

Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
TOWA PHARMACEUTICAL CO.,LTD. Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.	Japan	4553
TSUMURA & CO. A leader in Japanese Kampo herbal medicine, producing prescription and OTC formulations.	Japan	4540
TURK İLAÇ VE SERUM SANAYİ A.Ş. Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.	Türkiye	TRILC
UCB Biopharma firm developing treatments for severe neurological and immunological diseases.	Belgium	UCB
Uni-Bio Science Group Ltd Develops biopharma therapies for endocrinology, ophthalmology, and dermatology needs.	Hong Kong	N/A
UNION KOREA PHARM CO.,Ltd Develops and manufactures prescription drugs like antibiotics and analgesics for global markets.	South Korea	080720
Univo Pharmaceuticals Ltd. Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.	Israel	UNVO-M
Valbiotis Develops clinically tested, plant-based supplements for metabolic & cardiovascular health.	France	ALVAL
Valneva SE Develops and commercializes vaccines for infectious diseases like chikungunya, Lyme, and Zika.	France	VLA
Vaxcell-Bio Therapeutics Develops CAR-T and CAR-NK immunotherapies for solid tumors and canine lymphoma.	South Korea	323990